SUSAN GROGAN: Open Payments
NPI 1437291861 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 56 payments from 22 companies in 2025. Trend: 2023 $222 · 2024 $323 · 2025 $1,251
Food & beverage: $1,077Education: $174
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $277 |
| Incyte Corporation | 2 | $123 |
| Celgene Corporation | 5 | $96 |
| Merck Sharp & Dohme LLC | 4 | $75 |
| Daiichi Sankyo Inc. | 3 | $74 |
| E.R. Squibb & Sons, L.L.C. | 5 | $74 |
| AstraZeneca Pharmaceuticals LP | 2 | $61 |
| PFIZER INC. | 2 | $55 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Karyopharm Therapeutics Inc. | 2 | $50 |
Products named: KISQALI, SCEMBLIX, ENHERTU, REBLOZYL, KEYTRUDA, XPOVIO, Trodelvy, OPDUALAG.
Industry payments across MO — which companies pay providers there.
